Inc. Hexima Limited
Records under this name other than the patents Inc. Hexima Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,010,576 | Method of Treatment Lapsed on the fee record Ended Jul 3, 2026 · High confidence | Lapsed on the fee record | Ended Jul 3, 2026 | High confidence |
| US 9,713,632 | Method of Treatment Lapsed on the fee record Ended Jul 25, 2025 · High confidence | Lapsed on the fee record | Ended Jul 25, 2025 | High confidence |
| US 10,973,874 | Method of treatment Lapsed on the fee record Ended Apr 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 13, 2025 | From the USPTO record |
| US 9,497,908 | Modified plant defensins useful as anti-pathogenic agents Lapsed on the fee record Ended Nov 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2024 | From the USPTO record |
| US 10,568,930 | Agents and methods of treatment Lapsed on the fee record Ended Feb 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 25, 2024 | From the USPTO record |
| US 10,357,536 | Anti-pathogenic methods Lapsed on the fee record Ended Jul 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 23, 2023 | From the USPTO record |
| US 10,231,450 | Agents and methods for treatment of pathogens Lapsed on the fee record Ended Mar 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | From the USPTO record |
| US 9,943,564 | Anti-pathogenic methods Lapsed on the fee record Ended Apr 17, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2022 | From the USPTO record |
| US 9,896,697 | Defensin-encoding nucleic acid molecules derived from Nicotiana alata, uses therefor and transgenic plants comprising same Lapsed on the fee record Ended Feb 20, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 20, 2022 | From the USPTO record |
| US 9,889,184 | Anti-pathogen systems Lapsed on the fee record Ended Feb 13, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2022 | From the USPTO record |